Logo

CLINDAMYCIN UNDER SCRUTINY: What Dental Clinicians Should Know

Datum

Donnerstag, 27. August 2026

Zeit

15:00 America/Los Angeles

In meiner Zeitzone anzeigen
Dieses Feld ist erforderlich.
Dieses Feld ist erforderlich.
Dieses Feld ist erforderlich.
Dieses Feld ist erforderlich.
Dieses Feld ist erforderlich.
Erforderliche Felder
Wenn Sie sich bereits registriert haben und die Bestätigungsmail Ihrer Registrierung nicht finden können, klicken Sie bitte hier!
Die E-Mail-Adresse ist falsch. Bitte überprüfen Sie Ihre E-Mail-Adresse noch einmal.

Eine Bestätigungsmail mit den Protokolldaten wurde an die angegebene E-Mail-Adresse gesendet.

Systemkonfigurationstest. Hier klicken!

Agenda

TITLE:  Clindamycin Under Scrutiny: What Every Dental Clinician Should Know

COURSE FEE:  Complimentary Access

CREDITS: This continuing education activity is designated for 1 credit

DURATION: 60 minutes

AGD PACE SUBJECT CODE: 134 Prescription Medication Management

CE SUPPORTER: None

MODE: Electronically Mediated | Live Interactive Webinar

SPEAKER: Dr. Kirsten Roling, DDS (Bio below)

AUDIENCE: Dentists, Dental Hygienists, Dental Therapists, Dental Students

COURSE SUMMARY: For decades, clindamycin held a prominent place in dental practice, particularly for patients reporting a penicillin allergy and for the management and prevention of odontogenic infections. But evolving evidence regarding antimicrobial stewardship, adverse drug events, Clostridioides (Clostridium) difficile infection, and appropriate antibiotic selection has dramatically changed how clinicians should view this once-familiar dental standby.

This evidence-based continuing education course examines the history of clindamycin—from its development and pharmacology to its widespread adoption in medicine and dentistry—and explores the science that ultimately led to major changes in clinical recommendations. Participants will review clindamycin's composition, mechanism of action, antimicrobial spectrum, indications, and historical uses in dental practice, while examining its potential for serious adverse effects, including antibiotic-associated diarrhea and C. difficile infection.

Special attention will be given to the evidence behind the decision to no longer recommend clindamycin as an alternative for certain patients with penicillin allergy. The course will distinguish between situations in which clindamycin has fallen out of favor and circumstances in which it may still have a legitimate clinical role.

Through the lens of antibiotic stewardship and current evidence, dental professionals will leave with a clearer understanding of how recommendations changed, why they changed, and how thoughtful antibiotic selection can reduce preventable patient harm while supporting responsible antimicrobial prescribing.

TECHNOLOGY REQUIRED:  Mobile device, laptop or desktop with internet connection | Google Chrome Browser

INSTRUCTIONS:  Dental CE Academy hosts all webinars using the ClickMeeting platform. Upon registration you are sent a confirmation email from no-reply@clickeeting.com with a link to join. Be sure to check your spam/junk/promotions folders. We recommend logging in 15 minutes early in the event you require assistance. 

HANDOUTS:  Distributed via email to all attendees 1 hour prior to start, during and after the webinar. 

QUIZ FOR CE CREDIT VERIFICATION: At the conclusion of the webinar, attendees will be redirected to complete a quiz for CE credit. An 80% minimum passing score is required, multiple attempts are permitted, and attendees have 7 days to successfully complete the quiz for CE credit.

LEARNING OBJECTIVES: 

  • Describe the history and pharmacology of clindamycin, including its development, mechanism of action, antimicrobial spectrum, and introduction into dental practice.

  • Identify the historical and contemporary dental indications for clindamycin and differentiate appropriate therapeutic use from routine or unnecessary antibiotic prescribing.

  • Explain the adverse-effect profile associated with clindamycin, with particular emphasis on antibiotic-associated diarrhea, disruption of the intestinal microbiome, and Clostridioides difficile infection.

  • Discuss the evidence and evolving professional recommendations that led to clindamycin falling out of favor for certain dental indications, including changes involving antibiotic prophylaxis for patients reporting penicillin allergy.

  • Compare clindamycin with alternative antibiotic options based on clinical indication, patient history, allergy status, antimicrobial spectrum, safety, and principles of antibiotic stewardship.

  • Apply current evidence and antimicrobial stewardship principles to dental prescribing decisions to minimize unnecessary antibiotic exposure, reduce adverse events, and promote safer patient care.


DISCLOSURE OF SPEAKER AND FACULTY COMMERCIAL RELATIONSHIPS:  According to Dental CE Academy's Conflict of Interest and Disclosure Policy, faculty and speakers for any course are expected to disclose any economic support, personal interests, or potential bias that may be perceived as creating a conflict related to the material being presented. Disclosure statements are printed in each course description and announced by moderators or individual speakers at the beginning of each presentation. This policy is intended to alert the audience to any potential bias or conflict so that participants may form their own judgments about the material being presented.

CONFLICT OF INTEREST AND FINANCIAL DISCLOSURE: This course is not sponsored.  The speaker, Dr. Kirsten Roling is the Chief Education Officer and employee of Dental CE Academy. She has not received an honorarium for this presentation. For written documentation you may contact support@dentalcenow.com.

DENTAL CE ACADEMY DISCLOSURE: The views expressed and opinions and materials presented during these live and recorded presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy.  Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based up on the speakers' own clinican experience and should not be construed as Dental CE Academy recommended or endorsed. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to new interest and scientific breakthroughs in the fields of dentistry.  Dental CE Academy appreciates its educators who share their knowledge and expertise. This level of dedication to dentistry allows our profession to expand and thrive and provokes necessary discussion and understanding. 

Dr. Kirsten Roling, DDS

Dr. Kirsten Roling, DDS, serves as the Chief Education Officer for Dental CE Academy, She completed her dental training at the University of California, San Francisco, during the critical period of the HIV/AIDS Pandemic. Prior to her achievement as a dentist she was a Registered Dental Assistant and dental practice management consultant. As a public health dentist, Dr. Roling is recognized as an early pioneer of Teledentistry, formerly in clinical practice that encompassed both pediatrics and geriatrics. Her previous roles include Assistant Clinical Professor at UCSF and Public Health Preceptor at the Arizona School of Dentistry and Oral Health. Additionally, she served as Chief of the Office of Oral Health for Maricopa County's Department of Public Health, where she managed the nation's largest pediatric oral health prevention programs within the third largest public health department in the U.S. As a mobile dental provider, she led a mobile practice focused on treating homebound geriatric patients and is a recipient of the Pediatric Oral Health Access Program scholarship. She is published in the Journal of Public Health Dentistry, and notably a #cdiffsurvivor.